Skip to main content

Treatment Advances For Slow-Growing Non-Hodgkin Lymphomas

March 29, 2019

[Click here to enlarge.] 

Topics Covered

We invite you to learn more about:

  • The importance of knowing your non-Hodgkin lymphoma (NHL) subtype 
  • Current and emerging therapies 
  • Managing side-effects of treatment 
  • The benefit of discussing quality-of-life concerns with your healthcare team



Jonathon B. Cohen, MD, MS
Assistant Professor, Hematology and Medical Oncology
Director, Lymphoma Clinical Trials Working Group
Winship Cancer Institute of Emory University
Atlanta, GA

Audio Replay

Program Materials

Program Support

 Support for this program is provided by Bristol-Myers Squibb; Genentech and Biogen; Pharmacyclics, an AbbVie company and Janssen Biotech.


< Back to Webcasts